Dr. Justin James Carroll, MD

Dr. Carroll practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Carroll's NPI, 1801327622, was assigned on March 23, 2017. Dr. Carroll holds Indiana license 01083830A.

Dr. Carroll's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Carroll's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Carroll is also affiliated with John Peter Smith Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Carroll to 1 more hospital, 4 medical groups, 1 behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carroll practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Carroll's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Carroll is licensed in Indiana.

CMS data shows 276 Medicare services from Dr. Carroll across 6 procedure codes in 2024, for 291 Medicare patients. Medicare paid $23,499 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 291 Medicare patients who saw Dr. Carroll in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carroll's median patient age at 52, with 59% women.

In 2024, Dr. Carroll wrote 205 Medicare Part D claims for 161 patients. 93% of them were for generic drugs. CMS names the drug for 142 of them, across 9 drugs with 11 or more claims each, at $657 in total drug cost. In 2023, CMS named 131 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Carroll for performance year 2024, reported through an alternative payment model (APM). Dr. Carroll accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Carroll from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $131.